Net Asset Value
The Board of The Law Debenture Corporation p.l.c. announces that its Net Asset
Value (NAV Ex Income) at 31 May 2011 was 355.35 pence per share and NAV Cum
Income was 360.69 pence per share. The mid-market price at the close of
business that day was 372.40 pence per share.
In accordance with listing rule 15.6.8, The Law Debenture Corporation p.l.c.
announces that it has no investments in other UK listed investment companies
that require to be disclosed. Its top ten holdings, including all holdings with
a value greater than 5% of the Corporation's gross assets as at 31 May 2011 are
set out below
Top 10 Holdings
The top 10 holdings in the portfolio as at 31 May 2011 were:
Rank Name of Holding % of portfolio
(excl. cash)
1. Royal Dutch Shell 3.33
2. Senior 3.22
3. Henderson Asia Pacific Capital Growth 2.75
4. BP 2.73
5. HSBC 2.51
6. Henderson Japan Capital Growth 2.43
7. GlaxoSmithKline 2.32
8. GKN 2.23
9. British American Tobacco 2.09
10. Baillie Gifford Pacific 2.05
Geographical Split
Region % of portfolio
UK 71
Europe 10
North America 6
Japan 4
Other Pacific 8
Other -
Cash and Fixed Interest 1
TOTAL 100
Released by The Law Debenture Corporation p.l.c., Fifth Floor, 100 Wood Street,
London, EC2V 7EX (contact Ian Bowden, Company Secretariat, 020 7696 5285).
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.